An article titled “Pulmonary arterial hypertension redefined” published June 9, 2016, misstated the authors’ financial disclosures. Funding was provided by educational grants from Bayer and United Therapeutics Corporation. All but two coauthors had no disclosures; the remaining authors disclosed numerous ties to industry sources.


You May Also Like

Medicare may expand preventive prediabetes coverage

Expanded Medicare coverage of preventive services for type 2 diabetes may mean providers will ...

Long-term depression prevalent in schizophrenia patients

FROM SCHIZOPHRENIA RESEARCH Persistent depression, or “trait” depression, was significantly higher in patients with ...